NASDAQ:ACHV Achieve Life Sciences Q2 2026 Earnings Results & Report $7.41 0.00 (0.00%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$7.22 -0.19 (-2.50%) As of 04:27 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Achieve Life Sciences missed analyst earnings expectations in its Q2 2026 results, released August 11, 2026. The company reported EPS of -$0.80 versus the -$0.1649 consensus estimate. Research:ProfileEarnings HistoryForecast Earnings Announcement Details QuarterQ2 2026Report DateAugust 11, 2026TimeBefore Market OpensConference Call4:00 PM ET Achieve Life Sciences EPS ResultsActual EPS-$0.80Consensus EPS -$0.1649Beat/MissMissed by -$0.6351One Year Ago EPSN/AEPS Beat Rate1 of last 8 quartersAchieve Life Sciences Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AUpcoming EarningsAchieve Life Sciences' Q3 2026 earnings is estimated for Thursday, November 5, 2026, based on past reporting schedules, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q3 2026 Earnings ReportConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Achieve Life Sciences Q2 2026 Earnings FAQ Did Achieve Life Sciences beat earnings estimates for Q2 2026? Achieve Life Sciences (NASDAQ:ACHV) reported earnings of -$0.80 per share for Q2 2026, missing the consensus estimate of -$0.1649. The report was announced on Tuesday, August 11, 2026. When is Achieve Life Sciences' next earnings date? Achieve Life Sciences' next earnings date is estimated for Thursday, November 5, 2026. MarketBeat tracks confirmed and estimated earnings dates for Achieve Life Sciences on the company's earnings history page. Achieve Life Sciences Earnings HeadlinesAchieve Life Sciences, Inc. Announces Appointment of Kaitlyn Tuson as Senior Vice President, Marketing and CommunicationsOctober 8, 2026 | marketscreener.comMAchieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and CommunicationsOctober 7, 2026 | globenewswire.comTrump To Relaunch USD?President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may be a bid to reset the US dollar. Porter Stansberry says the meeting, attended by figures like Elon Musk, Jensen Huang and Larry Fink, connects to a 13-nation pact designed to cut China out of a massive investment wave. | Porter & Company (Ad)Achieve Life Sciences Announces Granting of New Hire Inducement AwardsOctober 6, 2026 | globenewswire.comAchieve Life Sciences, Inc. Announces CFO Changes, Effective October 5, 2026October 1, 2026 | marketscreener.comMAchieve Life Sciences Appoints Benjamin Halladay As CFOOctober 1, 2026 | rttnews.comSee More Achieve Life Sciences Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Achieve Life Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Achieve Life Sciences and other key companies, straight to your email. Email Address About Achieve Life SciencesAchieve Life Sciences (NASDAQ:ACHV) is a biopharmaceutical company focused on developing and commercializing cytisinicline, a plant-based investigational therapy intended to help adults quit smoking and address nicotine addiction. Cytisinicline is designed to act on nicotinic acetylcholine receptors in the brain, potentially reducing nicotine cravings and withdrawal symptoms while helping limit the satisfaction associated with smoking. The company’s primary development program is aimed at securing regulatory approval for cytisinicline in the United States. Achieve has evaluated the therapy in clinical studies involving adults who smoke cigarettes and has also investigated its potential use in helping people quit vaping or using other nicotine products. Cytisinicline has a history of use in certain countries outside the United States under different brand names, although Achieve is conducting its own clinical and regulatory development program for the U.S. market. Achieve Life Sciences is headquartered in Seattle, Washington, and its operations are centered on clinical development, regulatory activities and commercialization planning for cytisinicline. The company’s leadership includes Chief Executive Officer Rick Stewart, who has experience in the development and commercialization of pharmaceutical products.View Achieve Life Sciences ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Q3 Earnings Could Blow Past Consensus—Be Ready for What Comes NextDelta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
